Description

BSE announces listing and admission to dealings of Commercial Paper worth Rs.250 crores issued by Samvardhana Motherson International Limited on private placement basis.

Summary

BSE has listed and admitted to dealings new Commercial Paper issued by Samvardhana Motherson International Limited on private placement basis, effective from November 7, 2025. The issue comprises 5,000 units of Commercial Paper with a face value of Rs.5,00,000 each, totaling Rs.250 crores. The securities are rated ICRA A+ and IND A1+ with ICICI Bank Limited serving as the Issuing and Paying Agent.

Key Points

  • Total issue size: 5,000 units of Rs.5,00,000 each (Rs.250 crores)
  • Scrip Code: 730513, Scrip ID: SMI061125
  • ISIN: INE775A14798
  • Issue price: Rs.4,96,680.50 per unit
  • Credit rating: ICRA A+, IND A1+
  • Market lot: 1 unit
  • Trading only in dematerialized form
  • Standard denomination: Rs.5 lakhs and multiples thereof
  • Tick size: 1 paise
  • Issuing and Paying Agent: ICICI Bank Limited

Regulatory Changes

No regulatory changes. This is a standard listing announcement.

Compliance Requirements

  • Trading members must trade these securities only in dematerialized form under ISIN INE775A14798
  • Trading must be conducted in standard denomination of Rs.5 lakhs and multiples thereof
  • Tick size of 1 paise must be observed

Important Dates

  • Notice Date: November 7, 2025
  • Listing Date: November 7, 2025
  • Allotment Date: November 6, 2025
  • Redemption Date: December 17, 2025

Impact Assessment

This is a routine commercial paper listing with minimal market impact. The short-term debt instrument has a tenure of 41 days and is part of normal corporate treasury operations. Impact is limited to debt market participants and investors in commercial paper. The credit rating of A1+ indicates strong safety characteristics for short-term debt obligations.

Impact Justification

Routine commercial paper listing announcement with short tenure (41 days). Standard operational notice for debt market participants with no regulatory changes or compliance requirements.